Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G

Vaccine

Volumn 23, Issue 41, 2005, Pages 4921-4925

  Sanz Moreno, Juan Carlos ^a   Limia Sánchez, Aurora ^a   García Comas, Luis ^a   Mosquera Gutiérrez, Ma Mar ^b   Echevarria Mayo, Juan Emilio ^b   Castellanos Nadal, Ana ^b   De Ory Manchón, Fernando ^b  

^a Instituto de Salud Pública de la Comunidad de Madrid ^*  (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Avidity; Mumps; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUMPS VACCINE;

ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG PROTEIN BINDING; HUMAN; IMMUNE STATUS; MUMPS; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; TREATMENT FAILURE;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; TREATMENT FAILURE;

EID: 24144492703     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.05.018     Document Type: Article

References (26)

1. A. Shulman, B. Shohat, D. Gillis, H. Yavetz, Z.T. Homonnai, and G. Paz Mumps orchitis among soldiers: frequency, effect on sperm quality, and sperm antibodies Fertil Steril 57 6 1992 1344 1346
2. G. Feldman, and M. Zer Infantile acute pancreatitis after mumps vaccination simulating an acute abdomen Pediatr Surg Int 16 7 2000 488 489
3. R.C. Parmar, S.B. Bavdekar, D.R. Sahu, S. Warke, and J.R. Kamat Thyroiditis as a presenting feature of mumps Pediatr Infect Dis J 20 6 2001 637 638
4. G. Kanra, A. Kara, A.B. Cengiz, M. Ceyhan, and A. Atas Mumps meningoencephalitis effect on hearing Pediatr Infect Dis J 21 12 2002 1167 1169
5. Nuevo Calendario vacunal 1996 Boletín Epidemiológico de la Comunidad de Madrid 19 1996 25 27
6. Calendario vacunal 1999. Boletín Epidemiológico de la Comunidad de Madrid 1999;4:50-9.
7. III Encuesta de Serovigilancia de la Comunidad de Madrid. Boletín Epidemiológico de la Comunidad de Madrid 2002;8(5):3-41.
8. Informe de brotes epidémicos 2001. Boletín Epidemiológico de la Comunidad de Madrid 2002;8(2):45-67.
9. C.S. Pannuti, R.J. Morello, J.C. Moraes, S.P. Curti, A.M. Afonso, and M.C. Camargo Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic Clin Diagn Lab Immunol 11 1 2004 119 122
10. E. Castells, V.G. George, and J.C. Hierholzer NCI-H292 as an alternative cell line for the isolation and propagation of the human paramyxoviruses Arch Virol 115 3-4 1990 277 288
11. M. Narita, S. Yamada, Y. Matsuzono, O. Itakura, T. Togashi, and H. Kikuta Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection Clin Diagn Lab Immunol 3 2 1996 211 215
12. M. Narita, Y. Matsuzono, Y. Takekoshi, S. Yamada, O. Itakura, and M. Kubota Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G Clin Diagn Lab Immunol 5 6 1998 799 803
13. C. Amela, I. Pachón, and F. de Ory Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey Eur J Epidemiol 18 1 2003 71 79
14. L.E. Visser, K.C. Gonzalez Perez, J. Ramos Tejera, A.C. Berjón Barrientos, Y. Vergara Guerrero, and J.F. Martinez Navarro An outbreak of mumps in the Province of Leon, Spain Euro Surveill 3 2 1998 14 18
15. M. Montes, G. Cilla, J. Artieda, D. Vicente, and M. Basterretxea Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain Epidemiol Infect 129 3 2002 551 556
16. C. Pons, T. Pelayo, I. Pachón, A. Galmes, L. González, and C. Sánchez Two outbreaks of mumps in children vaccinated with the Rubini strain in Spain indicate low vaccine efficacy Euro Surveill 5 7 2000 80 84
17. C. Cruz Rojo, M. Rodríguez Iglesias, J. Olvera, and M. Alvarez Girón Study of the immune response engendered by different combined measles, mumps and rubella (MMR) vaccines in an area of Andalusia (Spain) Vaccine 22 2 2003 280 286
18. B. Crowley, and M.A. Afzal Mumps virus reinfection - clinical findings and serological vagaries Commun Dis Public Health 5 4 2002 311 313
19. J.P. Gut, C. Lablache, S. Behr, and A. Kirn Symptomatic mumps virus reinfections J Med Virol 45 1 1995 17 23
20. M. Narita, S. Yamada, H. Kikuta, and T. Togashi Reconstitution of humoral immunity during pregnancy Am J Reprod Immunol 44 3 2000 148 152
21. F. Lista, G. Faggioni, M.S. Peragallo, F. Tontoli, A. Stella, and P. Salvatori Molecular analysis of early postvaccine mumps-like disease in Italian military recruits JAMA 287 9 2002 1114 1115
22. B.J. Cohen, L. Jin, D.W. Brown, and M. Kitson Infection with wild-type mumps virus in army recruits temporally associated with MMR vaccine Epidemiol Infect 123 2 1999 251 255
23. F. De Ory, I. Casas, C.J. Domingo, and J.M. Echevarría Application of fluoroimmunoassay to the identification of low avidity specific IgG against pathogenic human viruses and Toxoplasma gondii Clin Diagn Virol 3 1995 323 332
24. R.G. Pebody, N.J. Gay, L.M. Hesketh, A. Vyse, P. Morgan-Capner, and D.W. Brown Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance Vaccine 20 7-8 2002 1134 1140
25. M. Paunio, K. Hedman, I. Davidkin, and H. Peltola IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy Expert Opin Pharmacother 4 8 2003 1215 1225
26. M. Paunio, K. Hedman, I. Davidkin, M. Valle, O.P. Heinonen, and P. Leinikki Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age Epidemiol Infect 124 2 2000 263 271